1. Targeted and activatable nanosystem for fluorescent and optoacoustic imaging of immune-mediated inflammatory diseases and therapy via inhibiting NF-κB/NLRP3 pathways
- Author
-
Shuizhu Wu, Yunqing Ma, Lihe Sun, Cheng Zeng, Juan Ouyang, Zhuo Zeng, and Fang Zeng
- Subjects
QH301-705.5 ,Biomedical Engineering ,Inflammation ,Article ,Biomaterials ,chemistry.chemical_compound ,Actively-targeting nanosystem ,medicine ,NF-κB/NLRP3 pathways ,Macrophage ,Two-mode imaging ,Biology (General) ,Materials of engineering and construction. Mechanics of materials ,Chemistry ,NF-κB ,Prodrug ,medicine.disease ,Fluorescence ,Cancer research ,TA401-492 ,Immune-mediated inflammatory diseases ,Immune-mediated inflammatory disease ,NLRP3 inflammasome activation ,medicine.symptom ,Optoacoustic imaging ,Biotechnology - Abstract
Immune-mediated inflammatory diseases (IMIDs) represent a diverse group of diseases and challenges remain for the current medications. Herein, we present an activatable and targeted nanosystem for detecting and imaging IMIDs foci and treating them through blocking NF-κB/NLRP3 pathways. A ROS-activatable prodrug BH-EGCG is synthesized by coupling a near-infrared chromophore with the NF-κB/NLRP3 inhibitor epigallocatechin-3-gallate (EGCG) through boronate bond which serves as both the fluorescence quencher and ROS-responsive moiety. BH-EGCG molecules readily form stable nanoparticles in aqueous medium, which are then coated with macrophage membrane to ensure the actively-targeting capability toward inflammation sites. Additionally, an antioxidant precursor N-acetylcysteine is co-encapsulated into the coated nanoparticles to afford the nanosystem BH-EGCG&NAC@MM to further improve the anti-inflammatory efficacy. Benefiting from the inflammation-homing effect of the macrophage membrane, the nanosystem delivers payloads (diagnostic probe and therapeutic drugs) to inflammatory lesions more efficiently and releases a chromophore and two drugs upon being triggered by the overexpressed in-situ ROS, thus exhibiting better theranostic performance in the autoimmune hepatitis and hind paw edema mouse models, including more salient imaging signals and better therapeutic efficacy via inhibiting NF-κB pathway and suppressing NLRP3 inflammasome activation. This work may provide perceptions for designing other actively-targeting theranostic nanosystems for various inflammatory diseases., Graphical abstract Image 1, Highlights • A multifunctional nanosystem has been developed for targeting, imaging and treating immune-mediated inflammatory diseases. • Once activated the nanosystem generates fluorescent/optoacoustic signals for diagnosis and evaluating therapeutic efficacy. • The released drugs EGCG and NAC in inflammation site treat the diseases via inhibiting NF-κB/NLRP3 pathways.
- Published
- 2022